Navigation Links
2 UCLA faculty elected to National Academy of Sciences
Date:5/10/2013

Two professors from the David Geffen School of Medicine at UCLA have been elected by their peers to the prestigious National Academy of Sciences in recognition of their distinguished and continuing achievements in original research.

Election to the academy is considered one of the highest honors presented to scientists in the U.S.; its membership includes Albert Einstein, Robert Oppenheimer, Thomas Edison, Orville Wright and Alexander Graham Bell.

The UCLA professors are among 84 new members of the academy from across the U.S. and 21 foreign associates from 14 countries. Their election brings the number of current UCLA academy members to 43. The new UCLA members are:

Dr. Edward De Robertis, Norman Sprague Professor of Biological Chemistry and a Howard Hughes Medical Institute investigator. De Robertis is a member of the Pontifical Academy of Sciences and the Latin American Academy of Sciences, as well as a fellow of the American Academy of Arts and Sciences. His research focuses on the way that cells communicate with each other.

De Robertis' isolation of genes that control head-to-tail and back-to-belly patterning in early frog and mouse embryos led to the discovery that all animals' development is controlled by an ancient genetic toolkit. In particular, he carried out the molecular dissection of the process of embryonic induction, in which groups of cells called "organizers" control tissue differentiation. This work is aimed at understanding cell signaling, a fundamental problem in stem cell biology and cancer. De Robertis has been a member of the Jonsson Comprehensive Cancer Center at UCLA since 1985.

Ernest Wright, distinguished professor of physiology and Sherman M. Mellinkoff Distinguished Professor in Medicine. Wright was named a fellow of the British Royal Society in 2005, an honor considered one of the highest accolades a scientist can achieve next to the Nobel Prize, and in 2006 he was elected to the German Academy of Sciences Leopoldina. His research focuses on the structure, function and genetics of membrane transport proteins, which act as the gatekeepers for the body by carrying essential molecules in and out of cells.

Research in Wright's laboratory on the cloning and function of glucose transporters has already led to the development of new drugs to control diabetes.


'/>"/>

Contact: Elaine Schmidt
eschmidt@mednet.ucla.edu
310-794-2272
University of California - Los Angeles
Source:Eurekalert

Related biology news :

1. 3 NYU faculty elected to National Academy of Sciences
2. Winners of the 2012 F1000Prime Faculty Member of the Year Awards
3. UMass Medical School faculty elected to the American Association for the Advancement of Science
4. U of M faculty find antimicrobials altering intestinal bacteria composition in swine
5. 2 UNC faculty receive Autism Centers of Excellence grants for new research
6. IU biologist receives Department of Energys top young faculty award
7. Fred Hutch evolutionary geneticist Harmit Malik selected as an HHMI investigator
8. OU microbiologists elected as fellows in the American Academy of Microbiology
9. Freeman elected to National Academy of Science
10. Carnegies Greg Asner elected to National Academy of Sciences
11. 87 scientists elected to the American Academy of Microbiology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)... SAN FRANCISCO , Feb. 13, 2017 /PRNewswire/ ... a centralized platform that is designed to enhance ... the latest release in the RSA Fraud & ... to enable organizations to leverage additional insights from ... anti-fraud tools to better protect their customers from ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... -- Summary This report provides all the ... partnering interests and activities since 2010. Description The Partnering ... into the partnering activity of one of the world,s leading ... prepared upon purchase to ensure inclusion of the most up ... will be delivered in PDF format within 1 working day ...
(Date:3/28/2017)... March 28, 2017  Viking Therapeutics, Inc. ("Viking") (NASDAQ: ... of novel therapies for metabolic and endocrine disorders, today ... , Ph.D., will deliver a corporate presentation at H.C. ... Conference, being held April 3, 2017 at the St. ... for this presentation are as follows: ...
(Date:3/28/2017)... ... March 28, 2017 , ... Currently symptomatic therapies for ... recent study published in STEM CELLS suggests that human neural stem cell (hNSC) ... to produce more neural cells. , Strategies involving transplantation of these cells ...
(Date:3/28/2017)... Triangle Park, NC (PRWEB) , ... March 28, ... ... development company engaged in the development of a new orally administered treatment for ... Advisory Board. , CEO John Didsbury states, “As we seek to uniquely treat ...
Breaking Biology Technology: